Skip to main content
. 2022 Jun 30;17(6):e0269998. doi: 10.1371/journal.pone.0269998

Fig 4. The ROC curve of CCBL2 in breast carcinoma cohort.

Fig 4

Normal and tumor samples (A). The AUC (0.659) indicated a limited diagnostic capability. Subgroup analyses: Stage Ⅰ (B) (AUC: 0.592), Stage Ⅱ (C) (AUG:0.673), Stage Ⅲ (D) (AUG:0.659), Stage Ⅳ (E) (AUG:0.828). Abbreviations: AUC, area under the curve; ROC, receiver operating characteristic.